Diclegis is a combination of doxylamine succinate and pyridoxine hydrochloride. After lawsuits claiming its link to birth defects, the product was withdrawn from the market in 1983 due to the manufacturer’s financial difficulty in defending itself in the court. Since that time, the FDA has confirmed that the active ingredients in Diclegis do not pose a risk to the fetus. How often do you counsel pregnant women experiencing morning sickness? How would you counsel patients regarding the safety and the efficacy of this drug?
For more information, please click here